Nanoplatforms for Cancer Theranostics

SEP 11, 2026 · JOURNAL ARTICLE

A novel multi-functional FeZnCuInS/ZnS-TPPS4 conjugates as a promising theragnostic tool for combined photodynamic and photothermal therapy applications

Next Materials

In vitro proof-of-concept study of a novel nanomaterial showing biocompatibility and physical properties favourable for dual PDT/PTT, but no efficacy data, no in vivo work, and no comparison to standard therapies.

SEP 11, 2026 · JOURNAL ARTICLE

Green-Synthesized Nanomaterials for Kidney Cancer: Current Progress and Future Perspectives

International Journal of Molecular Sciences

This is a narrative review synthesizing preclinical and early-stage evidence on green-synthesized nanomaterials for kidney cancer, raising mechanistic questions rather than reporting clinical trial data or definitive efficacy.

SEP 10, 2026 · JOURNAL ARTICLE

The CD73-adenosine axis in NSCLC: expression regulation, pro-tumor mechanisms, and combination therapy

Journal of Cancer Research and Clinical Oncology

A narrative review summarizing current evidence on CD73-adenosine biology and therapeutic strategies in NSCLC, without new primary data or meta-analysis.

SEP 10, 2026 · JOURNAL ARTICLE

Sequential Mannose-Targeted Nanotherapy Orchestrates Tumor-Associated Macrophage Repolarization and Chemotherapeutic Response in Triple-Negative Breast Cancer

Acs Applied Bio Materials

Preclinical study in murine tumor model with surrogate endpoints (macrophage polarization, cytokine profile, cardiac markers) and no human data; promising mechanistic approach but requires clinical validation.

SEP 10, 2026 · JOURNAL ARTICLE

Programmable Organic A2S-TT NPs for NIR-II/Photoacoustic Imaging-Enabled Precision Therapy

Pharmaceutics

Preclinical proof-of-concept study in cell and mouse models of a novel nanoparticle platform; no human data, efficacy metrics lack quantitative comparison to standard therapy, and no phase 1 translation reported.

SEP 10, 2026 · JOURNAL ARTICLE

Advances in gold and silver nanoplatforms for photon therapies in breast cancer

Biophysical Reviews

A narrative review synthesizing preclinical mechanistic work and emerging nanoplatform designs, not reporting original clinical or trial data, and explicitly stating that clinical translation remains challenged and further studies are required.

SEP 10, 2026 · JOURNAL ARTICLE

Nanotoxicity and nanogenotoxicity in cancer therapy mechanisms dual roles and emerging mitigation strategies

Discover Materials

This is a mechanistic minireview that examines nanotoxicity pathways and mitigation strategies in cancer therapy without presenting new experimental data or clinical evidence, making it exploratory rather than confirmatory or practice-changing.

SEP 10, 2026 · JOURNAL ARTICLE

ROS-autocatalytic nanoplatform interfering astrocyte-cancer crosstalk and enhancing glioblastoma therapy

Nature Communications

Preclinical proof-of-concept study demonstrating a novel nanoplatform mechanism in cell and animal models, without human efficacy data or direct comparison to standard therapy.